Contact
Please use this form to send email to PR contact of this press release:
Jubilant Biosys Enters into Exclusive out-Licensing Agreement with Checkpoint Therapeutics for Novel BET Inhibitors
TO:
Please use this form to send email to PR contact of this press release:
Jubilant Biosys Enters into Exclusive out-Licensing Agreement with Checkpoint Therapeutics for Novel BET Inhibitors
TO: